Arkolith/Insider Trading/SYN/Form 4

Riley Jeffrey Scott

CEO and President, DirectorSynthetic Biologics, Inc. (SYN) · full profile →Form 4 · filed Jan 3, 2013
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2013Buy(P)3K$1.75$5K6K
Jan 2, 2013Buy(P)3K$1.78$5K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001144204-13-000459) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Synthetic Biologics, Inc.

Build

Ask your agent about SYN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001144204-13-000459"
Ask your agent
Use Arkolith to summarize insider buying and selling at Synthetic Biologics, Inc.
over the last 90 days and cite the filings.